628 related articles for article (PubMed ID: 36619546)
1. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
Bouadma L; Mekontso-Dessap A; Burdet C; Merdji H; Poissy J; Dupuis C; Guitton C; Schwebel C; Cohen Y; Bruel C; Marzouk M; Geri G; Cerf C; Mégarbane B; Garçon P; Kipnis E; Visseaux B; Beldjoudi N; Chevret S; Timsit JF;
JAMA Intern Med; 2022 Sep; 182(9):906-916. PubMed ID: 35788622
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study.
Martinez-Guerra BA; Gonzalez-Lara MF; Roman-Montes CM; Tamez-Torres KM; Dardón-Fierro FE; Rajme-Lopez S; Medrano-Borromeo C; Martínez-Valenzuela A; Ortiz-Brizuela E; Sifuentes-Osornio J; Ponce-de-Leon A
Emerg Microbes Infect; 2022 Dec; 11(1):50-59. PubMed ID: 34839785
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.
De la Cruz-Cano E; Jiménez-González CDC; Díaz-Gandarilla JA; López-Victorio CJ; Escobar-Ramírez A; Uribe-López SA; Huerta-García E; Ayala-Sumuano JT; Morales-García V; Gútierrez-López L; González-Garrido JA
F1000Res; 2022; 11():10. PubMed ID: 35464048
[No Abstract] [Full Text] [Related]
9. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
10. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.
Espiritu AI; Chiu HHC; Sy MCC; Anlacan VMM; ; Jamora RDG
Sci Rep; 2021 Dec; 11(1):24436. PubMed ID: 34952903
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
Søvik S; Barrat-Due A; Kåsine T; Olasveengen T; Strand MW; Tveita AA; Berdal JE; Lehre MA; Lorentsen T; Heggelund L; Stenstad T; Ringstad J; Müller F; Aukrust P; Holter JC; Nordøy I
J Infect; 2022 Jul; 85(1):57-63. PubMed ID: 35605805
[TBL] [Abstract][Full Text] [Related]
12. Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
Chen Z; Zhan Q; Huang L; Wang C
Front Public Health; 2023; 11():1195048. PubMed ID: 37711242
[TBL] [Abstract][Full Text] [Related]
13. Ventilator Acquired Pneumonia in COVID-19 ICU Patients: A Retrospective Cohort Study during Pandemia in France.
Moreno J; Carvelli J; Lesaux A; Boucekine M; Tonon D; Bichon A; Gainnier M; Bourenne J
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675351
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with poor outcomes among hospitalized patients with COVID-19: Experience from a MERS-CoV referral hospital.
Barry M; Alotaibi M; Almohaya A; Aldrees A; AlHijji A; Althabit N; Alhasani S; Akkielah L; AlRajhi A; Nouh T; Temsah MH; Al-Tawfiq JA
J Infect Public Health; 2021 Nov; 14(11):1658-1665. PubMed ID: 34627061
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study.
Ortega E; Corcoy R; Gratacòs M; Cos Claramunt FX; Mata-Cases M; Puig-Treserra R; Real J; Vlacho B; Castelblanco E; Domingo P; Khunti K; Franch-Nadal J; Mauricio D
BMJ Open; 2021 Jul; 11(7):e051237. PubMed ID: 34301668
[TBL] [Abstract][Full Text] [Related]
16. Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
Mirouse A; Friol A; Moreau AS; Jung B; Jullien E; Bureau C; Djibré M; de Prost N; Zafrani L; Argaud L; Reuter D; Calvet L; de Montmollin E; Benghanem S; Pichereau C; Pham T; Cacoub P; Biard L; Saadoun D
Sci Rep; 2023 Feb; 13(1):1902. PubMed ID: 36732353
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 pneumonia in patients with impaired fasting glucose, newly diagnosed diabetes and pre-existing diabetes: a tertiary center experience.
Boyuk B; Akin S; Aladag N; Isik A; Erman H; Ozgur Y; Topal M; Karademir N; Tomar Uysal B; Ozbilgehan B; Kabaca D; Kalmaz C; Arslan S; Keskin O
J Investig Med; 2022 Oct; 70(7):1481-1487. PubMed ID: 35654475
[TBL] [Abstract][Full Text] [Related]
18. Predicting the outcome of COVID-19 infection in kidney transplant recipients.
Oto OA; Ozturk S; Turgutalp K; Arici M; Alpay N; Merhametsiz O; Sipahi S; Ogutmen MB; Yelken B; Altiparmak MR; Gorgulu N; Tatar E; Ozkan O; Ayar Y; Aydin Z; Dheir H; Ozkok A; Safak S; Demir ME; Odabas AR; Tokgoz B; Tonbul HZ; Sezer S; Ates K; Yildiz A
BMC Nephrol; 2021 Mar; 22(1):100. PubMed ID: 33740915
[TBL] [Abstract][Full Text] [Related]
19. Dysglycemias in patients admitted to ICUs with severe acute respiratory syndrome due to COVID-19 versus other causes - a cohort study.
Réa RR; Bernardelli RS; Kozesinski-Nakatani AC; Olandoski M; Martins-Junior MJ; Oliveira MC; Réa-Neto Á
BMC Pulm Med; 2023 May; 23(1):173. PubMed ID: 37193970
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
